Human Integrin alpha V beta 3 Antibody Summary
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: Integrin alpha V beta 3
Integrin alpha V beta 3 together with alpha IIb beta 3, constitutes the only known beta 3 Integrins (1‑3). The non-covalent heterodimer of 170 kDa alpha V/CD51 and 93 kDa beta 3/CD61 subunits shows wide expression, notably by endothelial cells and osteoclasts (2‑4). Each subunit has a transmembrane sequence and a short cytoplasmic tail connected to the cytoskeleton. Active cell surface alpha V beta 3 adheres to matrix proteins including vitronectin, fibronectin, fibrinogen and thrombospondin (2, 3). The ligand binding site of alpha V beta 3 is in the N-terminal head region, formed by interaction of the beta 3 vWFA domain with the alpha V beta-propeller structure (4). The alpha V subunit contributes a thigh and a calf region, while the beta 3 subunit contains a PSI domain and four cysteine-rich I-EGF folds. The alpha V subunit domains termed thigh, calf-1 and calf-2 generate a “knee” region that is bent when the alpha V beta 3 is in its constitutively inactive state. Activation, either by “inside out” signaling or by Mg2+ or Mn2+ binding, extends the Integrin to expose its ligand binding site (1, 4). Two splice variants of beta 3 (b and c) diverge over the last 21 amino acids (aa) and lack cytoplasmic phosphorylation sites (5, 6). Another beta 3 splice variant diverges after the vWFA domain, producing a soluble 60 kDa form in platelets and endothelial cells (7). alpha V beta 3 is essential for the maturation of osteoclasts and their binding and resorption of bone; it also, however, promotes their apoptosis (8, 9). M-CSF R and alpha V beta 3 share signaling pathways during osteoclastogenesis, and deletion of either molecule causes osteopetrosis (8, 9). Also cell entry of several viruses is mediated by alpha V beta 3 (4, 10). The 962 aa human alpha V ECD (11) shares 92‑95% aa sequence identity with mouse, rat and cow alpha V while the 685 aa human beta 3 ECD (12) shares 95% aa identity with horse and dog, and 89‑92% aa identity with mouse, rat and pig beta 3.
- Hynes, R. O. (2002) Cell 110:673.
- Serini, G. et al. (2006) Exp. Cell Res. 312:651.
- Ross, F. P. and S. L. Teitelbaum (2005) Immunol. Rev. 208:88.
- Xiong, J. et al. (2001) Science 294:339.
- Kumar, C. S. et al. (1987) J. Biol. Chem. 272:16390.
- vanKuppevelt, H. et al. (1989) Proc. Natl. Acad. Sci. USA 86:5415.
- Djaffar, I. et al. (1994) Biochem. J. 300:67.
- McHugh, K. P. et al. (2000) J. Clin. Invest. 105:433.
- Faccio, R. et al. (2003) J. Clin. Invest. 111:749.
- Chu, J. J. and M. Ng (2004) J. Biol. Chem. 279:54533.
- Suzuki, S. et al. (1987) J. Biol. Chem. 262:14060.
- Fitzgerald, L. A. et al. (1987) J. Biol. Chem. 262:3936.
Product Datasheets
Citations for Human Integrin alpha V beta 3 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
15
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Potential of uPAR, alphavbeta6 Integrin, and Tissue Factor as Targets for Molecular Imaging of Oral Squamous Cell Carcinoma: Evaluation of Nine Targets in Primary Tumors and Metastases by Immunohistochemistry
Authors: M Lawaetz, A Christense, K Juhl, K Karnov, G Lelkaitis, AM Kanstrup F, A Kjaer, C von Buchwa
International Journal of Molecular Sciences, 2023-02-14;24(4):.
Species: Human
Sample Types: Whole Tissue
Applications: IHC -
Fungal sensing by dectin-1 directs the non-pathogenic polarization of TH17 cells through balanced type I IFN responses in human DCs
Authors: SI Gringhuis, TM Kaptein, EBM Remmerswaa, A Drewniak, BA Wevers, B Theelen, GRAM D'Haens, T Boekhout, TBH Geijtenbee
Nature Immunology, 2022-12-01;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant-driven tumor growth
Authors: SM Shin, JS Kim, SW Park, SY Jun, HJ Kweon, DK Choi, D Lee, YB Cho, YS Kim
Sci Adv, 2020-01-15;6(3):eaay2174.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
The post-abscission midbody is an intracellular signaling organelle that regulates cell proliferation
Authors: E Peterman, P Gibieža, J Schafer, VA Skeberdis, A Kaupinis, M Valius, X Heiligenst, I Hurbain, G Raposo, R Prekeris
Nat Commun, 2019-07-18;10(1):3181.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Acidic preconditioning of endothelial colony-forming cells (ECFC) promote vasculogenesis under proinflammatory and high glucose conditions in vitro and in vivo
Authors: HA Mena, PR Zubiry, B Dizier, M Schattner, C Boisson-Vi, S Negrotto
Stem Cell Res Ther, 2018-05-02;9(1):120.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
HLA Class II-Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection
Authors: YP Jin, NM Valenzuela, X Zhang, E Rozengurt, EF Reed
J. Immunol., 2018-02-23;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Functional Assay -
Osteopontin-integrin engagement induces HIF-1?-TCF12-mediated endothelial-mesenchymal transition to exacerbate colorectal cancer
Authors: CS Fan, WS Chen, LL Chen, CC Chen, YT Hsu, KV Chua, HD Wang, TS Huang
Oncotarget, 2017-12-22;9(4):4998-5015.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
AlphaVBeta3 Integrin expression within uterine endometrium in unexplained infertility: a prospective cohort study
Authors: A Elnaggar, AH Farag, ME Gaber, MA Hafeez, MS Ali, AM Atef
BMC Womens Health, 2017-09-26;17(1):90.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-P -
cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells
Authors: K Miyano, H Cabral, Y Miura, Y Matsumoto, Y Mochida, H Kinoh, K Iwata, O Nagano, H Saya, N Nishiyama, K Kataoka, T Yamasoba
J Control Release, 2017-06-27;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Osteopontin Promotes Oncostatin M Production in Human Osteoblasts: Implication of Rheumatoid Arthritis Therapy.
Authors: Su C, Chiang Y, Huang C, Hsu C, Fong Y, Tang C
J Immunol, 2015-08-24;195(7):3355-64.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Arachidonic acid and docosahexaenoic acid suppress osteoclast formation and activity in human CD14+ monocytes, in vitro.
Authors: Kasonga A, Deepak V, Kruger M, Coetzee M
PLoS ONE, 2015-04-13;10(4):e0125145.
Species: Human
Sample Types: Whole Cells
Applications: IHC -
C6-ceramide nanoliposome suppresses tumor metastasis by eliciting PI3K and PKCzeta tumor-suppressive activities and regulating integrin affinity modulation.
Authors: Zhang P, Fu C, Hu Y, Dong C, Song Y, Song E
Sci Rep, 2015-03-20;5(0):9275.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Mesenchymal stem cell contact promotes CCN1 splicing and transcription in myeloma cells.
Authors: Dotterweich J, Ebert R, Kraus S, Tower R, Jakob F, Schutze N
Cell Commun Signal, 2014-06-25;12(0):36.
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
The nexus between VEGF and NFkappaB orchestrates a hypoxia-independent neovasculogenesis.
Authors: DeNiro M, Al-Mohanna F, Alsmadi O, Al-Mohanna F
PLoS ONE, 2013-03-22;8(3):e59021.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
The role of RGD-tagged helical rosette nanotubes in the induction of inflammation and apoptosis in human lung adenocarcinoma cells through the P38 MAPK pathway.
Authors: Suri SS, Rakotondradany F, Myles AJ, Fenniri H, Singh B
Biomaterials, 2009-02-27;30(17):3084-90.
Species: Human
Sample Types: Whole Cells
Applications: ICC
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human Integrin alpha V beta 3 Antibody
There are currently no reviews for this product. Be the first to review Human Integrin alpha V beta 3 Antibody and earn rewards!
Have you used Human Integrin alpha V beta 3 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image